Boston Partners’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Boston Partners’s Portfolio NXGN Stock Details NXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-204,030	Closed	-$2.79M	–	819
2018 Q1	$2.79M	Hold	204,030	–	–	﹤0.01%	605
2017 Q4	$2.77M	Hold	204,030	–	–	﹤0.01%	626
2017 Q3	$3.21M	Hold	204,030	–	–	﹤0.01%	600
2017 Q2	$3.51M	Sell	204,030 -33,466	-14%	-$509K	﹤0.01%	556
2017 Q1	$3.62M	Hold	237,496	–	–	﹤0.01%	555
2016 Q4	$3.12M	Hold	237,496	–	–	﹤0.01%	599
2016 Q3	$2.69M	Hold	237,496	–	–	﹤0.01%	613
2016 Q2	$2.83M	Buy	237,496 +27,210	+13%	+$366K	﹤0.01%	580
2016 Q1	$3.21M	Hold	210,286	–	–	﹤0.01%	534
2015 Q4	$3.39M	Hold	210,286	–	–	﹤0.01%	535
2015 Q3	$2.62M	Buy	210,286 +87,908	+72%	+$1.21M	﹤0.01%	575
2015 Q2	$2.03M	Hold	122,378	–	–	﹤0.01%	619
2015 Q1	$1.96M	Sell	122,378 -9,550	-7%	-$158K	﹤0.01%	624
2014 Q4	$2.06M	Hold	131,928	–	–	﹤0.01%	630
2014 Q3	$1.82M	Buy	+131,928	New	+$2M	﹤0.01%	644

Other funds holding NXGN

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners's NXGN Position: Q2 2018 in Review

Boston Partners sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q2 2018, closing a stake of 204,030 shares — an estimated $2.79M sold.

Boston Partners first reported a position in NXGN in Q3 2014 and held it in 15 quarters. The position peaked at $3.62M in Q1 2017. 165 funds tracked by Wall St. Rank hold NXGN as of Q2 2018.

Boston Partners reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Boston Partners sold 204,030 NextGen Healthcare, Inc. Common Stock shares in Q2 2018, an estimated $2.79M.
Boston Partners first reported a position in NextGen Healthcare, Inc. Common Stock in Q3 2014 and held it in 15 quarters.
Boston Partners's NextGen Healthcare, Inc. Common Stock position peaked at $3.62M in Q1 2017.
165 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q2 2018.

Based on Boston Partners's 13F filing for Q2 2018, filed 3 Aug 2018.